Publication

Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancer

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Baiyu Yang, Emory UniversityAaron P. Thrift, Baylor College of MedicineJane C. Figueiredo, University of Southern CaliforniaMark A. Jenkins, University of MelbourneFredrick R. Schumacher, University of Southern CaliforniaDavid V. Conti, University of Southern CaliforniaYi Lin, Fred Hutchinson Cancer Research CenterAung Ko Win, University of MelbournePaul J. Limburg, Mayo ClinicSonja I. Berndt, National Cancer InstituteHermann Brenner, German Cancer Research CenterAndrew T. Chan, Harvard Medical SchoolJenny Chang-Claude, German Cancer Research CenterMichael Hoffmeister, German Cancer Research CenterThomas J. Hudson, University of TorontoLoic Le Marchand, University of HawaiiPolly A. Newcomb, Fred Hutchinson Cancer Research CenterMartha L. Slattery, University of UtahEmily White, Fred Hutchinson Cancer Research CenterUlrike Peters, University of WashingtonGraham Casey, University of Southern CaliforniaPeter Campbell, Emory University
Language
  • English
Date
  • 2016-10-01
Publisher
  • Elsevier Science Ltd.
Publication Version
Copyright Statement
  • © 2016 Elsevier Ltd. All rights reserved.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 44
Start Page
  • 1
End Page
  • 4
Grant/Funding Information
  • None declared
Supplemental Material (URL)
Abstract
  • Background: Obesity is a convincing risk factor for colorectal cancer. Genetic variants in or near FTO and MC4R are consistently associated with body mass index and other body size measures, but whether they are also associated with colorectal cancer risk is unclear. Methods: In the discovery stage, we tested associations of 677 FTO and 323 MC4R single nucleotide polymorphisms (SNPs) 100 kb upstream and 300 kb downstream from each respective locus with risk of colorectal cancer in data from the Colon Cancer Family Registry (CCFR: 1960 cases; 1777 controls). Next, all SNPs that were nominally statistically significant (p < 0.05) in the discovery stage were included in replication analyses in data from the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO: 9716 cases; 9844 controls). Results: In the discovery stage, 43 FTO variants and 18 MC4R variants were associated with colorectal cancer risk (p < 0.05). No SNPs remained statistically significant in the replication analysis after accounting for multiple comparisons. Conclusion: We found no evidence that individual variants in or near the obesity-related genes FTO and MC4R are associated with risk of colorectal cancer.
Author Notes
  • Correspondence to: Peter T. Campbell, Ph.D., Epidemiology Research Program, American Cancer Society National Home Office, 250 Williams Street NW, Atlanta, Georgia 30303. peter.campell@cancer.org; Tel: 404.327.6460; Fax: 404.327.6450
Keywords
Research Categories
  • Biology, Genetics
  • Health Sciences, Occupational Health and Safety
  • Health Sciences, Oncology

Tools

Relations

In Collection:

Items